Moxibustion Reduces Symptoms and Improves Quality of Life in Patients With Allergic Rhinitis

The Therapeutic Effect and Standardization of Moxibustion in the Treatment of Allergic Rhinitis

The objective of this randomized controlled clinical trial is to compare the therapeutic effect of moxibustion on allergic rhinitis. The main questions it aims to answer are:

Based on randomized controlled trials, verify the effectiveness of moxibustion in treating allergic rhinitis Based on a real-time monitoring system for human surface temperature, discuss the differences in therapeutic effects of different moxibustion doses on allergic rhinitis

Allergic rhinitis has a high incidence and is difficult to cure, seriously affecting the quality of life of patients Compare the effects of different moxibustion durations on the clinical efficacy and body surface temperature of patients with allergic rhinitis, and preliminarily explore the impact of different moxibustion doses on the efficacy of heavy moxibustion treatment for allergic rhinitis, providing evidence-based basis for clinical practice.

Inclusion criteria

• Those who meet the diagnostic criteria of Chinese and Western medicine for AR;
• Age range from 18 to 75 years old, regardless of gender;
• Patients and their families are informed and agree to the study.

Exclusion criteria

• Those who are undergoing other traditional Chinese medicine external treatment methods;
• Those who have taken traditional Chinese medicine recently or during treatment;
• Individuals who are allergic to heavy moxibustion smoke and dust;
• Individuals with concomitant bronchial asthma or other respiratory system diseases;
• Patients with severe skin diseases or ulcers in the local area where moxibustion is applied;
• Pregnant and lactating patients;
• Patients with severe diseases of important organs such as the heart, liver, lungs, and kidneys;
• Those who are unable to receive treatment according to regulations due to inconvenience in work, study, transportation, or personal activities